ArticleOncoimmunology2020

Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial.

Jianming Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.